Lifeboat Foundation

“Brainomix specialise in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions in stroke imaging”

https://www.openaccessgovernment.org/brainomix-stroke-imaging-solutions/122141/

The use of artificial intelligence (AI) technology has helped to triple the number of patients who recover from a stroke in England.

Continue reading “AI is helping doctors spot and treat strokes much faster” »

Check out some of the best AI-powered technology at this year’s Consumer Technology Association (CES) event in Las Vegas.

The 2023 Consumer Technology Association’s (CES) annual event is once again in full flow in Las Vegas.

Continue reading “9 of the best AI applications from CES 2023” »

ChatGPT3 became the newest internet sensation last year when it allows users to generate text and answer complex questions in a manner that seems almost human. But, beyond the prowess of ChatGPT3, the underlying impact of the technology — generative AI — on business is only just coming into focus.

ChatGPT3, together with its image-generating cousin Dall-E, has the potential to revolutionize the way content is created, from blogs to white papers, student essays to business correspondence. It provides access to expert-level syntax and grammar to anyone who uses it. But this also raises some important ethical questions.

This is not the first time that technology has captured the attention of the public. IBM Watson made headlines in 2011 when it won the television game show Jeopardy! and Amazon’s AMZN virtual assistant, Alexa, has been answering questions through smart speakers since its commercial debut in 2014.

Let me pick up where I left off ahead of Christmas by reiterating the fives themes for 2023 (‘War by Other Means’) that I had put together with David Skilling. The note details the trends we expect to materialise through the year as intense strategic competition between regions takes hold.

ChatGPT brings AI into our everyday lives, highlighting also its use in many other domains such as medicine and justice.

Allowing the driver of an autonomous vehicle to watch a movie, a dealer to sell automobiles from a “virtual” car lot, or an engineer to simulate how a new part fits: the auto industry is getting a tantalizing taste of the metaverse at the huge CES technology show.

One gadget on display in Las Vegas is an in-car television system, developed by French parts maker Valeo, that needs no remote.

To change the channel, drivers or passengers wearing a headset make a simple swipe in the air with their hand, and sensors in the car detect the movement.

Tech companies showed off their latest products this week at CES, formerly known as the Consumer Electronics Show.

Generative AI and creative innovation go hand in hand that capture people’s attention in 2023. Here in this article, we are going to it explain how.

Check out all the on-demand sessions from the Intelligent Security Summit here.

At their best, AI systems extend and augment the work we do, helping us to realize our goals. At their worst, they undermine them. We’ve all heard of high-profile instances of AI bias, like Amazon’s machine learning (ML) recruitment engine that discriminated against women or the racist results from Google Vision. These cases don’t just harm individuals; they work against their creators’ original intentions. Quite rightly, these examples attracted public outcry and, as a result, shaped perceptions of AI bias into something that is categorically bad and that we need to eliminate.

While most people agree on the need to build high-trust, fair AI systems, taking all bias out of AI is unrealistic. In fact, as the new wave of ML models go beyond the deterministic, they’re actively being designed with some level of subjectivity built in. Today’s most sophisticated systems are synthesizing inputs, contextualizing content and interpreting results. Rather than trying to eliminate bias entirely, organizations should seek to understand and measure subjectivity better.

Powered by data produced by its AI-driven discovery platform, clinical-stage biotech BioAge Labs is rapidly developing a pipeline of therapies to extend healthy lifespan by targeting the molecular causes of aging. Having raised more than $120 million in funding, and with multiple clinical trials already under its belt, the company is focused on building a broad pipeline of potential longevity therapies in three main areas: muscle, immune, and brain aging.

Longevity. Technology: There are few companies in the longevity biotech field that appear to be executing on their vision as quickly and consistently as BioAge. When the company wowed the sector with a $90 million funding round in 2020, talk of multiple imminent clinical trials may have sounded optimistic to some, but BioAge has delivered on its promise time and again. Beyond the trials already underway, the company’s much-vaunted AI discovery platform also appears to be churning out the data, this year spawning a new programme exploring the potential of NLRP3 inhibitors in brain aging. To learn more, we caught up with BioAge co-founder and CEO Kristen Fortney.

Looking back at 2022, Fortney says it has been “immensely gratifying” to see so many new companies and investors coming into the longevity field.